Association of Alterations in ParC and GyrA Proteins with Resistance of Clinical Isolates of Enterococcus faecium to Nine Different Fluoroquinolones
Open Access
- 1 October 1999
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 43 (10) , 2513-2516
- https://doi.org/10.1128/aac.43.10.2513
Abstract
The parC and gyrA genes of 73 ciprofloxacin-resistant and 6 ciprofloxacin-susceptible Enterococcus faecium clinical isolates were partly sequenced. Alterations in ParC and GyrA, possibly in combination with other resistance mechanisms, severely restricted the in vitro activities of the nine quinolones tested. For all isolates, clinafloxacin and sitafloxacin showed the best activities.Keywords
This publication has 26 references indexed in Scilit:
- Current susceptibilities of staphylococci to glycopeptides determined as part of an international resistance surveillance programme. Sentry Antimicrobial Surveillance ProgramJournal of Antimicrobial Chemotherapy, 1998
- Comparison of the antibacterial activities of the quinolones Bay 12- 8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin [published erratum appears in J Antimicrob Chemother 1998 Jun;41(6):672]Journal of Antimicrobial Chemotherapy, 1997
- Analysis of gyrA and grlA mutations in stepwise-selected ciprofloxacin-resistant mutants of Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1995
- Analysis by PCR and direct DNA sequencing of gyrA mutations associated with fluoroquinolone resistance in Enterococcus faecalisAntimicrobial Agents and Chemotherapy, 1994
- Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States I. Study on the threat of emerging resistances: Real or perceived?Diagnostic Microbiology and Infectious Disease, 1994
- Comparative in vitro activity of DU-6859a, a new fluoroquinolone agent, against gram-positive cocciAntimicrobial Agents and Chemotherapy, 1994
- Increasing problems in the therapy of enterococcal infectionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1993
- The enterococcus: a classic example of the impact of antimicrobial resistance on therapeutic optionsJournal of Antimicrobial Chemotherapy, 1991
- Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coliAntimicrobial Agents and Chemotherapy, 1990
- In vitro activities of quinolones against enterococci resistant to penicillin-aminoglycoside synergyAntimicrobial Agents and Chemotherapy, 1989